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Methods: In this prospective study, a l l  blood cultures submitted for mycobacteria detection, taken mainly from HIV- 
infected patients, were incubated for 12 weeks. The clinical impact of a late positive blood culture result was assessed 
retrospectively. 
Results: From a total of 750 blood cultures, 68 had a growth index (GI) >I0 due to the presence of mycobacteria. Of 
545 negative blood cultures with a GI <I0 within 12 weeks examined by Ziehl-Neelsen, one bottle revealed acid-fast 
bacilli further identified as Mycobacterium genavense by PCR-restriction fragment length polymorphism analysis of the 
hsp65gene. For six of 39 patients with positive blood cultures, the delay to positivity was >6 weeks (one M. tuberculosis, 
three M. genavense, two M. avium intracellulare complex). The prolonged incubation and the systematic terminal 
Ziehl-Neelsen increased the recovery of M. genavense from 5% to 14.5%. However, for only three patients did the late 
microbiological result lead to the introduction of antimycobacterial therapy. 
Conclusions: Neither a prolonged incubation longer than 6 weeks nor a terminal Ziehl-Neelsen-stained smear of the 
negative blood cultures at 12 weeks seem to be clinically justified. 
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INTRODUCTION 
Around 25% of HIV-infected patients present dis- 
seminated mycobacteriosis, mainly due to Myco- 
bacterium avium intracellulare complex (MAC) and to a 
lesser extent to other mycobacteria, such as M .  kansasii 
or M.  genavense [1,2]. The frequency of isolation of the 
newly recognized fastidious pathogen M. genavense 
varies greatly. It represents up to 12.8% of all dis- 
seminated mycobacterial infections in HIV-infected 
patients [3] .  This species fails to grow on normal solid 
media but shows limited multiplication in Bactec liquid 
broth, characterized by weak COZ release. In addition, 
an absence of correlation between the number of bacilli 
and the growth index (GI) has been reported [4,5]. 
Therefore, a systematic Ziehl-Neelsen-stained smear 
examination could improve the detection of M. 
genavense in Bactec blood cultures with a GI under 
the cut-off value. Moreover, a 6-week incubation 
period, as recommended by the American Society for 
Microbiology [6,7], could be insuficient to detect 
slowly growing fastidious mycobacteria. Aware of the 
higher incidence of M .  genavense in our region and 
of the incomplete efficiency of the Bactec system in 
detecting such slow-growing mycobacteria, we decided 
to determine the rate and the clinical impact of myco- 
bacteria detection in blood cultures by a prolonged 
incubation of 6-12 weeks and/or final systematic 
Ziehl-Neelsen-stained smears after 12 weeks of 
incubation. 
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In this prospective study, all Bactec blood culture 
bottles (Bactec 13A, Becton Dickinson Diagnostic 
Instrument Systems, Maryland, USA) submitted for 
mycobacteria detection between 1 January 1994 and 
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16 August 1995 were incubated for 12 weeks. These 
samples were taken mainly from symptomatic HIV- 
infected patients with CD4 counts under 50/mm3. The 
routine mycobacterial blood culture medium was a 
13A broth. Five milliliters of blood were inoculated 
directly into 13A vials at the bedside. Bactec bottles 
were incubated at  37OC for 12 weeks in an aerobic 
atmosphere. Vials were read for release of I4CO2 twice 
weekly for the first 2 weeks, weekly for the next 4 
weeks, and once after 9 and 12 weeks of incubation. 
Ziehl-Neelsen staining was used to confirm the 
presence of acid-fast bacteria in blood cultures with a 
radiometric growth index (GI) > 10. Isolates were 
identified using conventional biochemical tests, nucleic 
acid probe (Gen-Probe, San Diego, California, USA) 
and/or PCR restriction analysis [8]. About 0.1 mL of 
broth with an elevated GI was spread on blood agar 
plates in order to detect any possible contamination 
with bacteria other than mycobacteria. After 12 weeks 
of incubation, smears of most (545/673) of the blood 
culture bottles with a GI < 10 were carefully examined 
by Ziehl-Neelsen staining over 15-20 min. The clinical 
impact of a late positive blood culture was assessed 
retrospectively for every patient with a positive Bactec 
blood culture after >6 weeks of incubation and for 
the patient for whom rnycobacteria were detected in 
the blood culture at 12 weeks by the systematic 
Ziehl-Neelsen-stained smear examination. A clinical 
impact was defined as the introduction of anti- 
mycobacterial treatment following the positive Bactec 
result. An absence of clinical impact was considered 
when (1) an empirical antimycobacterial agent was 
introduced before the result of the Bactec blood 
culture, (2) in the presence of any other previous 
positive sample(s) for the same mycobacteria, (3) death 
had occurred during the period of incubation and was 
not related to a mycobacterial infection, and (4) when 
antimycobacterial agents were not introduced despite 
the positive blood culture result. 
RESULTS 
Seven hundred and fifty blood culture bottles for 
mycobacteria detection from 378 patients were 
analyzed between 1 January 1994 and 16 August 1995 
(Table 1). Sixty-two (8%) had a GI > l o  due to the 
presence of mycobacteria. The directed Ziehl-Neelsen 
smear done when a previous culture taken from the 
same patient yielded mycobacteria led to the detection 
of six additional positive blood cultures despite a GI 
< 10 (four MAC, two M. genavense). Overd ,  MAC was 
the most frequently recovered mycobacteriuin (n=51, 
74%), followed by M .  genavense (n=10, 14.5%) and 
M. tuberctrlosis (n=5 ,  7%); M. kansasii was found in two 
blood culture bottles, and M. haemophilum in one. 
Ninety-six per cent (45/47) of MAC were detected 
within 6 weeks, compared to 37% (3/8) of M.  genavense 
(p=0.0003). Due to directed Ziehl-Neelsen, the time 
of incubation was not taken into account for six blood 
cultures. 
Nine bottles were found to be contaminated by 
bacteria. From the remaining 673 (90%) Bactec blood 
culture bottles, no  production of I4CO2 was detected 
(GI < 10) during the entire 12-week incubation period. 
Of these 673 negative blood cultures, 545 were care- 
fully checked by a terminal Ziehl-Neelsen-stained 
smear for the presence of any mycobacteria. Acid-fast 
bacilli were seen in one bottle only and were further 
identified as M. genavense by P C R  restriction fragment 
length polymorphism analysis of the ksp65 gene. Thus, 
of 333 patients with negative blood culture, for only 
one did a routine Ziehl-Neelsen stain of the 'negative' 
blood culture broth lead to the detection of M .  
genavense. 
The prolonged incubation period of 6-12 weeks 
allowed the radiometric detection of eight of 68 
positive blood cultures (12%), (two MAC detected at  
9 weeks; five M .  genavense (in three patients) and 
one M. tuberculosis at 12 weeks). Thus, for six of 39 
patients (15%) with positive blood cultures for myco- 
bacteria, the delay to positivity was >6 weeks. For one 
additional patient, the final systematic Ziehl-Neelsen 
of a radiometric negative bottle led to the detection 
of M .  genavense. All seven were symptomatic AIDS 
patients with CD4 <50 mm3. Two of them had a 
clinical benefit from this late positive result, both with 
M. genavense recovered after 12 weeks of incubation. 
Both were still alive 6 months after the beginning of 
therapy directed to M. genavense. Another patient 
presented symptoms suggestive of disseminated M .  
genavense and was treated empirically at blood culture 
Table 1 Results of 750 blood cultures for mycobacteria 
detection taken from 378 patients between January 1994 
and August 1995 
No. of 
Culture blood cultures (96) 
Positive" 68 (9) 
Within 6 weeks 60 (8) 
Contaminated 9 (1) 
Between 6 and 12 weeks 8 (1) 
Negative" 673 (90) 
Ziehl-Neelsen negative 544 (73) 
Ziehl-Neelsen not done 128 (17) 
Ziehl-Neelsen posihve 1' - 
No. of 
patients (96) 
39 (10) 
(2) 
7 ( 2 )  
33 (8) 
332 (88) 
1' - 
- - 
- - 
"Culture positive for mycobacteria. bGI < 10 within 12  weeks. 
'Negative blood culture (GI <lo), where acid-fast bacilli were seen 
and further identified as M.  genavrnse by PCR restriction analysis 
(I'RA) . 
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sampling. Three additional patients had no clinical 
benefit from the late positive culture result (two MAC, 
one M. tuberculosis). Indeed, one patient died of an 
unrelated cause and two had already had another earlier 
positive sample. 
A clinical impact was also found for the single 
positive result obtained by the systematic final smear 
examination. Indeed, this 44-year-old patient, with 
HIV seropositivity known since 1991, and a CD4 cell 
count below 50, presented with weight loss, fever, 
pancytopenia, and fatigue. At the time of sampling, the 
patient had no fever and was not severely symptomatic. 
The systematic Ziehl-Neelsen done after 84 days 
of incubation led to the diagnosis of M.  genavense 
bacteremia. Combined antimycobacterial therapy 
(rifampicin, clofazimine, ciprofloxacin, clarithromycin) 
was introduced, with a subsequent clinical improve- 
ment. 
DISCUSSION 
Nine per cent of 750 Bactec 13A blood culture bottles 
were positive for mycobacteria. This recovery rate is 
similar to those reported, ranging from 7% to 13% 
[9,10]. As previously observed [3,11], MAC was the 
most commonly recovered mycobacterium in our 
study (74%) and M. genavense was recovered in only 5% 
of positive samples, when considering only a 6-week 
incubation. These recovery rates are consistent with 
those observed by others [3,11]. An increased sensitivity 
due to the prolonged incubation, to the directed search 
when another sample from the same patient was 
positive, and marginally due to the systematic terminal 
Ziehl-Neelsen smear examination, led to a higher 
total recovery rate of M.  genavense (14.5%). A higher 
prevalence of M.  genavense in Switzerland is also 
possible; M.  genavense was found in 12.8% of non- 
tuberculous disseminated mycobacterial infections in 
patients with HIV infection from 1990 to 1992 in Swiss 
university hospitals [ 121. 
In 1988, Spark and Fried reported that incubating 
mycobacterial culture specimens on the Bactec 460 TB 
system (Becton Dickinson Microbiology Systems, 
Maryland, USA) beyond 5 weeks did not significantly 
improve microbial recovery [ 131. Nevertheless, as some 
slow-growing mycobacteria have only recently been 
described [4,14,15], a six-week incubation could be 
insuficient to detect them by culture. Based on their 
experience with M. genavense, Coyle et a1 proposed an 
8-week incubation for all blood cultures [5]. Our 
study effectively showed a significantly lower level of 
detection of M. genavense (37%) than of MAC (96%) 
after 6 weeks of incubation. Blood cultures in Bactec 
13A medium were reported to require a mean of 58 
days (range 41-87) to detect growth of M.  genavense, in 
contrast to a mean of 10 days for MAC [16]. However, 
the group of Reves proposed, in a recent study [17], 
to decrease the detection time to 4 weeks, as (1) the 
incidence of M. genavense is too low to warrant routine 
prolongation of the incubation and testing period, and 
(2) the recovery of M.  genavense was more reliably 
improved by examining smears from bottles with GI 
values that persist between 10 and 100 than by 
prolonged incubation. 
The significantly different outcome between treated 
patients (median survival of 263 days) and untreated 
patients (median survival of 81 days) with M .  genavense 
disseminated infection [ 121 should trigger an aggressive 
search for M. genavense, including prolonged incuba- 
tion, or broader or earlier empirical therapy. However, 
the implications of a prolonged incubation for the 
laboratory workload and cost should be balanced 
against the clinical impact of the late positive results. 
Even if as many as 15% (6/39) of the patients with 
positive blood cultures for mycobacteria were detected 
because of a prolonged incubation of 6-12 weeks, a 
clinical impact was found for only two patients, both 
of them with a M .  genavense disseminated infection. 
The systematic terminal Ziehl-Neelsen-stained 
smear examination of all blood culture bottles done at 
12 weeks did not significantly improve the detection 
rate for M. genavense. Indeed, only one of 544 blood 
cultures was positive, despite a GI below 10 within 12 
weeks of incubation. 
Therefore, we believe that neither a prolonged 
incubation longer than 6 weeks nor a routine Ziehl- 
Neelsen of the negative blood cultures at 12 weeks is 
clinically justified in mycobacterial blood cultures. 
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